Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Trial compares 1% Terbinafine vs 1% Clotrimazole C...
A randomized controlled trial showed that for Tinea pedis (athletic foot) management, 1 week Terbinafine twice a day is as effective as 4 weeks C...
3 min
Study assesses efficacy of ketorolac for treatment...
In people presenting with migraine headache, ketorolac might have similar effectiveness when compared to phenothiazines and metoclopramide for mi...
3 min
Study reveals the effect of Isotretinoin on menstr...
Novel findings from a recent prospective observational study shed light on the impact of oral intake of Isotretinoin on menstrual cycles among ac...
1 min
Paracetamol vs Ibuprofen. Which is better for trea...
In a systematic review and meta-analysis, both Paracetamol and Ibuprofen demonstrated superior effectiveness compared to a placebo in addressing...
3 min
Tirzepatide injection gets FDA approval for chroni...
According to the notification published on 8 Nov 2023, the United States Food and Drug Administration (US-FDA) has authorized Tirzepatide injecti...
4 min
Is alcohol safe for rheumatoid arthritis patients...
Rheumatoid Arthritis (RA) patients taking Methotrexate (MTX) are often advised to decrease their alcohol intake due to the increased risk of hepa...
2 min
Does exercise induce GERD or relieve acid reflux?...
Different factors are accountable for the impact of exercise or physical activity on the onset of gastroesophageal reflux disease (GERD), a sessi...
3 min
GERD Symptoms: Could Intermittent Fasting Help?
A study published in the "Journal of Clinical Gastroenterology" showed symptomatic relief in gastroesophageal reflux disease (GERD) sym...
2 min
Microneedling + minoxidil boosts hair regrowth in...
In a systematic review and meta-analysis, combining microneedling with minoxidil offered markedly better outcomes for individuals with androgenet...
1 min
Understanding bleeding patterns associated with ea...
A recent study published in the Maternal-Fetal Medicine Journal found that terminated bleeding after 2 weeks is a predictive indicator for effe...
2 min
Prodrug-based strategies enhance drug delivery across the blood–b...
Prodrug-based approaches show substantial improvements in brain drug delivery, with some candidates showing up to 15-fold higher brain uptake and...
Preemptive analgesia in dental implant surgery: Which drugs offer...
Preemptive use of etoricoxib 90 mg, ibuprofen 600 mg and nimesulide 100 mg shows favorable pain-control outcomes in single-implant procedures, wh...
Low-histamine and pseudoallergen diets improve QoL in chronic urt...
Short-term dietary modifications—particularly pseudoallergen and histamine restrictions—improve symptom scores and quality of life in...
Intravenous ferric derisomaltose boosts maternal & neonatal outco...
A single, 24-minute IV infusion of ferric derisomaltose (1000 mg) rapidly elevates maternal hemoglobin levels and enhances infant iron reserves w...
Guselkumab maintains remission in ulcerative colitis through 92 w...
Guselkumab maintains clinical remission in up to 74% of patients with ulcerative colitis through 92 weeks, with nearly all patients in remission...
Elevated soluble CD163 levels reveal immune involvement in CRPS
Serum soluble CD163 levels are elevated in complex regional pain syndrome patients, reflecting macrophage activation and providing a measurable b...
FDA clears first oral PCSK9 inhibitor for management of high chol...
FDA approves enlicitide as the first oral PCSK9 inhibitor, delivering a groundbreaking once-daily pill option to slash "bad" cholestero...
Tapinarof 1% cream gains strong guideline support for children wi...
The 2026 AAD guidelines strongly recommend tapinarof 1% cream for children aged ≥2 years with atopic dermatitis. It is the only steroid-free t...
Etripamil nasal spray receives FDA approval for rapid relief of P...
FDA has approved intranasal etripamil for paroxysmal supraventricular tachycardia, delivering fast, on-demand restoration of normal heart rhythm....
FDA clears new oral therapy rilzabrutinib for treatment-resistant...
FDA approves rilzabrutinib tablets as a new oral treatment option for adults with persistent or chronic ITP who show insufficient response to sta...
FDA expands access to omalizumab therapy with first interchangeab...
The FDA has authorized omalizumab-igec as the first interchangeable biosimilar to omalizumab for treating asthma, urticaria, chronic rhinosinusit...
FDA introduces front-of-package nutrition labels to tackle chroni...
The FDA has proposed requisition of front-of-package nutrition labels on most packaged foods to clearly display levels of saturated fat, sodium,...
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.